Eisaku Yoshida

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer

T. Shuin, T. Karashima, Hiroyuki Nishimoto, 2022, Cancer medicine.

Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma

Hiroyuki Yamamoto, F. Itoh, M. Seiki, 2017, Cancer science.

Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma

M. Honda, S. Kaneko, M. Seiki, 2021, Hepatology.

Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review

F. Itoh, M. Seiki, N. Koshikawa, 2019, International journal of molecular sciences.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

M. Nojima, T. Shuin, T. Karashima, 2017, Biomarker Research.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

M. Nojima, T. Shuin, T. Karashima, 2017, Biomarker Research.